Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter updates remove 'HHS Vulnerability Disclosure' and add a revision label 'Revision: v3.3.3'. The study content and status remain unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study, and updated the page revision to v3.3.2. The corresponding deletions reference PubMed-derived publications and list revision v3.2.0.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved the government funding status banner that warned about potential data delays and directed users to opm.gov for updates.SummaryDifference0.4%

- Check61 days agoChange DetectedUI/layout updates were applied to the Study Details page with no substantial changes to core study information such as eligibility, enrollment, endpoints, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check89 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

- Check96 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.